Microvascular insufficiency due to vessel occlusion ‐ venous occlusion (analysed by digit, · patients undergoing digital replantation after traumatic amputation
It is very uncertain whether low molecular weight heparin (LMWH) changes microvascular insufficiency due to vessel occlusion ‐ venous… compared with no LMWH (very low certainty).
1 finding from 1 review
Complication and adverse reactions ‐ wound bleeding (analysed by participant, · patients undergoing digital replantation after traumatic amputation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Success rate of replantation1 (analysed by participant) · patients undergoing digital replantation after traumatic amputation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Success rate of replantation1 (analysed by digit, · patients undergoing digital replantation after traumatic amputation
It is very uncertain whether low molecular weight heparin (LMWH) changes success rate of replantation1 (analysed by digit, compared with no LMWH (very low certainty).
1 finding from 1 review
Recurrent stroke of any type · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) probably leads to lower recurrent stroke of any type compared with placebo or no treatment (moderate certainty).
2 findings from 1 review
Stroke, myocardial infarction, or vascular death · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in major vascular event (composite of non‐fatal stroke, non‐fatal… compared with placebo or no treatment (high certainty).
1 finding from 1 review
Myocardial infarction · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in myocardial infarction compared with placebo or no treatment (high certainty).
1 finding from 1 review
Deaths due to vascular events · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) leads to lower vascular death compared with placebo or no treatment (high certainty).
1 finding from 1 review
Death by any cause · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in death by any cause compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Dementia · stroke and/or TIA
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in dementia compared with placebo or no treatment (high certainty).
1 finding from 1 review
White population, normotensive, SBP mmHg · White population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Asian population, normotensive, DBP mmHg · Asian population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Asian population, hypertensive, SBP mmHg · Asian population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Asian population, hypertensive, DBP mmHg · Asian population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Renin ng/ml/hour · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Aldosterone pg/mL · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Noradrenaline pg/mL · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Adrenaline pg/mL · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Cholesterol mg/dL · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Trigyceride mg/dL · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review